Home Sitemap Contact us Accessibility Statement Top of the page

Latest Industry news from Teva

Subscribe to News RSS feed

RSS (Rich Site Summary or Really Simple Syndication) is a format for delivering regularly changing web content. RSS means you can stay in touch with many different sources of news and information. It's quicker than revisiting a site several times a day to check for updates, and rather than having to look for new headlines, feed readers scan for updates and display them for you. By subscribing to the Teva RSS feed you will be kept up-to-date on all the latest Teva news from the UK. Find out more about RSS.

Respiratory Dilemmas nurse conference “resounding success”
25 April 2016

Respiratory Dilemmas nurse conference “resounding success”

Resoundingly positive feedback was received from the delegates at a recent nurse conference on “Respiratory dilemmas in practice”. The meeting was organised in collaboration between Teva Respiratory and Education for Health.

The conference was designed to support education and learning for respiratory nurses in an innovative and different way and attracted over 100 delegates. All places were filled just four days after opening! Delegates heard from experts in the respiratory field, patient case studies, and also about the future of e-connectivity in inhaler... More

Teva Selected as Partner for Test Bed Innovation Programme
22 January 2016

Teva Selected as Partner for Test Bed Innovation Programme

Teva is delighted that the Sheffield City Region, with Teva as one of its partners, has been selected as one of seven national Test Bed innovation centres to take part in a major new drive to modernise how the NHS delivers care. More

World MS Day 2014
28 May 2014

World MS Day 2014

Today (28th May) is World MS Day, a time to raise awareness of MS and for us to be proud of how we support MS charities all year round. More

David Cameron mentions Teva in his recent Israeli address
31 March 2014

David Cameron mentions Teva in his recent Israeli address

British Prime Minister David Cameron recently visited Teva’s Jerusalem site, when it was announced that Teva will invest around $20 million (£12 million) in dementia research in the UK. More